Prime Medicine, Inc. (PRME)
4.715
-0.52
(-10.02%)
USD |
NASDAQ |
Oct 30, 16:00
4.71
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Cash and Short Term Investments (Annual) : 177.68M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 177.68M |
| December 31, 2024 | 190.44M |
| December 31, 2023 | 121.66M |
| Date | Value |
|---|---|
| December 31, 2022 | 293.92M |
| December 31, 2021 | 269.62M |
| December 31, 2020 | 53.33M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 449.88M |
| Beam Therapeutics, Inc. | 1.245B |
| Twist Bioscience Corp. | 232.43M |
| Moderna, Inc. | 5.80B |
| Q32 Bio, Inc. | 48.30M |